Skip links

Paths to Success with ACA Risk Adjustment

Read Blog

Centene Corporation Signs Definitive Agreement to Divest Apixio to New Mountain Capital

Press

Centene Corporation Signs Definitive Agreement to Divest Apixio to New Mountain Capital

Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to sell Apixio, a leading artificial intelligence platform that enables value-based care, to New Mountain Capital, a growth-oriented investment firm with more than $37 billion in assets under management. Centene acquired Apixio in December 2020.

Read the full press release at Cision PR Newswire.

# # # # #

MEDIA CONTACT:
Hanna Bautz
Next PR
apixio@nextpr.com

Sign Up to Receive Updates on How Technology is Shaping the Way Healthcare is Delivered.